Perbedaan Puri Global Sukses Tbk. dan Organon Pharma Indonesia Tbk.: Puri Global Sukses Tbk. diperdagangkan di Rp159 (kapitalisasi pasar 162 M, volume 24 jam 9,39 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Puri Global Sukses Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| PURI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 162 M | 104,4 M |
Volume | 9,39 jt | — |
Lot | 93,89 rb | — |
Perputaran | 1,5 M | — |
Harga Rata-rata | 160,21 | — |
Nilai Transaksi | 1,5 M | — |
Harga Ekuilibrium Indikatif | 159 | — |
Volume Ekuilibrium Indikatif | 1,44 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Puri Global Sukses Tbk (Company) was established in Batam based on notarial deed No. 19 dated January 20, 2016 of Bun Hai, S.H.,M.Kn. The Company has carried out its activitiescommercially in 2017.
Selengkapnya di halaman PURI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →